Clinical and molecular response to alpha1-oleate treatment in patients with bladder cancer.
Farhan HaqSamudra SabariJaromir HáčekAntonín BrisudaMurphy Lam Yim WanMichele CavaleraParisa EsmaeiliMurphy Lam Yim WanShahram AhmadiMarek BabjukCatharina SvanborgPublished in: Cancer medicine (2024)
These dose-dependent anti-tumor effects of alpha1-oleate are promising and support the potential of alpha1-oleate treatment in patients with NMIBC.